BioNTech SE (Nasdaq: NASDAQ:BNTX) and OncoC4, Inc. (“OncoC4”), today announced positive preliminary data from the ongoing Phase 1/2 trial with the companies’ anti-CTLA-4 antibody...
Investing.com - BioNTech (NASDAQ: BNTX) reported first quarter EPS of €2.05, €1.90 better than the analyst estimate of €0.15. Revenue for the quarter came in at...
Here is your Pro Recap of the top takeaways from Wall Street analysts for the past five sessions, so you can make sense of another whirlwind week for markets: Upgrades at Meta,...
The S&P 500 has rallied to new 2023 highs amid debt ceiling optimism. I used the InvestingPro stock screener to search for undervalued stocks that analysts are still bullish on...
Biotech company Moderna (NASDAQ:MRNA) is seeing its shares trade under pressure in recent days after the company reported last week Phase 3 trial results for its flu vaccine...
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
| Average | 156.64 (+43.75% Upside) |
| High | 244.7978 |
| Low | 109.00 |
| Price | 108.97 |
| No. of Analysts | 15 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Sell | Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 145.41 | 145.41 | 145.41 | 0.00 | 0.00% | 0.00 | London | |||
| 1.75 | 1.75 | 1.75 | 0.00 | 0.00% | 0.00 | London | |||
| 0.2484 | 0.2484 | 0.2484 | +0.0084 | +3.50% | 703.10K | London | |||
| 39.90 | 39.90 | 39.90 | 0.00 | 0.00% | 0.00 | London | |||
| 0.35 | 0.35 | 0.35 | 0.00 | 0.00% | 0.00 | London | |||
| 506.00 | 509.00 | 503.00 | -2.00 | -0.39% | 14.06K | London | |||
| 160.00 | 160.00 | 160.00 | 0.00 | 0.00% | 0.00 | London | |||
Kentzderived | 934.00 | 934.50 | 933.50 | 0.00 | 0.00% | 0.00 | London | ||
| 171.75 | 171.75 | 171.75 | 0.00 | 0.00% | 0.00 | London | |||
| 916.50 | 924.00 | 908.50 | +0.50 | +0.06% | 20.07K | London | |||
| 172.80 | 172.80 | 172.80 | -3.00 | -1.73% | 15.03K | London | |||
| 171.67 | 171.67 | 170.80 | -0.33 | -0.19% | 19.33K | London | |||
| 199.77 | 203.03 | 199.70 | -0.83 | -0.41% | 12.55K | London | |||
| 13.70 | 13.70 | 13.70 | 0.00 | 0.00% | 0.00 | London | |||
Autonomy Corpderived | 2,551.00 | 2,552.50 | 2,549.00 | 0.00 | 0.00% | 0.00 | London |